𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impediments in the use of explicit ontologies for KBS development

✍ Scribed by Daniel E. O'Leary

Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
197 KB
Volume
46
Category
Article
ISSN
1071-5819

No coin nor oath required. For personal study only.

✦ Synopsis

This paper explores some of the impediments in the development of libraries of reusable ontologies . First , ontologies generated in multiple agent environments derive from political processes . As a result , it is impossible to choose an ontology that maximizes the utility of all agents in the process and the group . An ''ontology impossibility theorem'' is formulated and discussed . Second , ontologies are not necessarily stationary over relevant time periods , providing an impediment to librarying ontologies . Third , scaling up ontologies is a dif ficult matter . Fourth , since each ontology is the result of a political process , it is dif ficult to interface multiple ontologies .

πŸ“œ SIMILAR VOLUMES

The roles of scenario use in ontology de
The roles of scenario use in ontology development
✍ Jintae Lee πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 246 KB

With the recent focus on knowledge management and knowledge-based systems, the proper development of ontologies, that is, conceptual structures underlying these systems, has become critical. Also recently, the benefits of using scenarios in the development of artifacts have received much attention i

The development of composite circulating
The development of composite circulating biomarker models for use in anticancer drug clinical development
✍ Lee J. Lancashire; Darren L. Roberts; Caroline Dive; Andrew G. Renehan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 373 KB

## Abstract The development of informative composite circulating biomarkers predicting cancer presence or therapy response is clinically attractive but optimal approaches to modeling are as yet unclear. This study investigated multidimensional relationships within an example panel of serum insulin‐